Piper cubeba L. f. Nanoemulsion: Formulation and Effect on Antioxidant Activity in Rat's Hippocampus and Prefrontal Cortex

Authors

DOI:

https://doi.org/10.33084/bjop.v8i2.8720

Keywords:

Antioxidant, Nanoemulsion, Neuroprotective

Abstract

The previous study showed that Piper cubeba extract increased brain antioxidant capacity, alleviating cognitive impairment in rats. However, brain-targeted drug delivery is often limited by the blood-brain barrier. One of the approaches to overcome this obstacle is nanocarrier. This study aimed to formulate a nanoemulsion (NE) of P. cubeba extract and determine the antioxidant activity in the brain. The research begins with the determination of excipients and the formula of NE. The formula was then tested for globule size, polydispersity index, thermodynamic stability, zeta potential, pH, and viscosity. The globule's shape was determined using transmission electron microscopy (TEM). The antioxidant activity was tested by catalase and lipid peroxidase activity in the brain after giving NE orally for seven days. Formulations of NE resulted in nano-size globules and were stable thermodynamically. The NE formula significantly increased catalase and inhibited lipid peroxidase activities in the Rat's hippocampus and prefrontal cortex. This study resulted in a stable formula and low-cost production of P. cubeba extract NE, which is active as the brain's antioxidant and is feasible to develop as a neuroprotective agent for various neurodegenerative diseases.

Downloads

Download data is not yet available.

Author Biographies

References

Kakarla R, Karuturi P, Siakabinga Q, Viswanath MK, Dumala N, Guntupalli C, et al. Current understanding and future directions of cruciferous vegetables and their phytochemicals to combat neurological diseases. Phytother Res. 2024;38(3):1381–99. DOI: 10.1002/ptr.8122; PMID: 38217095

Almutary AG, Begum MY, Siddiqua A, Gupta S, Chauhan P, Wadhwa K, et al. Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer’s Disease and Other Neurological Disorders. Mol Neurobiol. 2025;62(6):7975-97. DOI: 10.1007/s12035-024-04654-y; PMID: 39956886

Olufunmilayo EO, Gerke-Duncan MB, Holsinger RMD. Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants. 2023;12(2):517. DOI: 10.3390/antiox12020517; PMCID: PMC9952099; PMID: 36830075

Ashok A, Andrabi SS, Mansoor S, Kuang Y, Kwon BK, Labhasetwar V. Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants. 2022;11(2):408. DOI: 10.3390/antiox11020408; PMCID: PMC8869281; PMID: 35204290

Mutoh T, Mutoh T, Taki Y, Ishikawa T. Therapeutic potential of natural product-based oral nanomedicines for stroke prevention. J Med Food. 2016;19(6):521–7. DOI: 10.1089/jmf.2015.3644; PMCID: PMC4904166; PMID: 27136062

Xu SY, Pan SY. The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Med Sci Monit Basic Res. 2013;19:37–45. DOI: 10.12659/MSMBR.883750; PMCID: PMC3638705; PMID: 23353570

Naqvi S, Panghal A, Flora SJS. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Front Neurosci. 2020;14:494. DOI: 10.3389/fnins.2020.00494; PMCID: PMC7297271; PMID: 32581676

Dwita LP, Iwo MI, Elfahmi, Mauludin R. Brain Antioxidant Properties of Piper cubeba L. Extracts and Essential Oil. Farmacia. 2023;71(2):296–302. DOI: 10.31925/farmacia.2023.2.9

Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, et al. Nanoemulsion components screening and selection: A technical note. AAPS PharmSciTech. 2009;10(1):69–76. DOI: 10.1208/s12249-008-9178-x; PMCID: PMC2663668; PMID: 19148761

Choudhury H, Fadhilah N, Zakaria B, Atdriann P, Tilang B, Tzeyung AS, et al. Formulation development and evaluation of rotigotine mucoadhesive nanoemulsion for intranasal delivery. J Drug Deliv Sci Technol. 2019;54:101301. DOI: 10.1016/j.jddst.2019.101301

Hadwan MH. Simple spectrophotometric assay for measuring catalase activity in biological tissues. BMC Biochem. 2018;19:7. DOI: 10.1186/s12858-018-0097-5

Shakeel F, Haq N, Alanazi FK, Alsarra IA. Impact of various nonionic surfactants on self-nanoemulsification efficiency of two grades of Capryol (Capryol-90 and Capryol-PGMC). J Mol Liq. 2013;182:57-63. DOI: 10.1016/j.molliq.2013.03.011

de Souza RF, de Moraes SRA, Augusto RL, Zanona AdF, Matos D, Aidar FJ, et al. Endurance training on rodent brain antioxidant capacity: A meta-analysis. Neurosci Res. 2019;145:1-9. DOI: 10.1016/j.neures.2018.09.002; PMID: 30326252

Davis CK, Vemuganti R. Antioxidant therapies in traumatic brain injury. Neurochem Int. 2022;152:105255. DOI: 10.1016/j.neuint.2021.105255; PMCID: PMC11884749; PMID: 34915062

Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97(10):2499-574. DOI: 10.1007/s00204-023-03562-9; PMCID: PMC10475008; PMID: 37597078

Lalkovičová M, Danielisová V. Neuroprotection and antioxidants. Neural Regen Res. 2016;11(6):865–74. DOI: 10.4103/1673-5374.184447; PMCID: PMC4962567; PMID: 27482198

Gupta P, Kaur T, Lavisha M, Monika G. Role of inflammation and oxidative stress in chemotherapy ‑ induced neurotoxicity. Immunol Res. 2022;70(6):725-41. DOI: 10.1007/s12026-022-09307-7; PMID: 35859244

Rastegar-Moghaddam SH, Alipour F, Hosseini M, Ebrahimzadeh-bideskan A. Anti-apoptotic and neurogenic properties in the hippocampus as possible mechanisms for learning and memory improving impacts of vitamin D in hypothyroid rats during the growth period. Life Sci. 2023;312:121209. DOI: 10.1016/j.lfs.2022.121209; PMID: 36410409

Lee KH, Cha M, Lee BH. Neuroprotective Effect of Antioxidants in the Brain. Int J Mol Sci. 2020;21(19):7152. DOI: 10.3390/ijms21197152; PMCID: PMC7582347; PMID: 32998277

Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis. 2008;15(3):473-93. DOI: 10.3233/jad-2008-15314; PMCID: PMC2669703; PMID: 18997301

Fachel FNS, Schuh RS, Veras KS, Bassani VL, Koester LS, Henriques AT, et al. An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders. Neurochem Int. 2019;122:47–58. DOI: 10.1016/j.neuint.2018.11.003; PMID: 30439384

Subedi L, Gaire BP. Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases. Pharmacol Res. 2021;169:105661. DOI: 10.1016/j.phrs.2021.105661; PMID: 33971269

Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019;16(3):666–74. DOI: 10.1007/s13311-019-00767-8; PMCID: PMC6694352; PMID: 31376068

Nandi A, Yan L, Jana CK, Das N. Review Article Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases. Oxid Med Cell Longev. 2019;2019:9613090. DOI: 10.1155/2019/9613090; PMCID: PMC6885225; PMID: 31827713

Sigurdsson T, Duvarci S. Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease. Front Syst Neurosci. 2016;9:190. DOI: 10.3389/fnsys.2015.00190; PMCID: PMC4727104; PMID: 26858612

Downloads

Published

05/30/2025

Issue

Section

Pharmacology-Toxicology

Categories

How to Cite

1.
Dwita LP, Iwo MI, Mauludin R, Elfahmi E. Piper cubeba L. f. Nanoemulsion: Formulation and Effect on Antioxidant Activity in Rat’s Hippocampus and Prefrontal Cortex. Borneo J Pharm [Internet]. 2025 May 30 [cited 2026 Nov. 9];8(2):149-57. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/8720

Similar Articles

71-80 of 111

You may also start an advanced similarity search for this article.